We need more money for research to discover and test new and better drugs and other forms of treatment.
We have come a long way in the past 20 years. New drugs like thalidomide, lenalidomide, bortezimib, and others have revolutionized the treatment of multiple myeloma – but they don’t prevent progression of myeloma forever.
- We need Congress to maintain and add to the annual research budget of the National Cancer Institute (and we work with several partners to support this initiative)
- We need the pharmaceutical and biotechnology industries to develop innovative new agents that are better than what we have today – and bring them to market as fast as they can.
- We need to understand how we can prevent and limit the risk for myeloma, so that future generations can avoid the problems associated with this disease.
Have a look at What YOU Can Do to help.
To get the details about our advocacy priorities, look at our Statement of Principles.